SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-22-157739
Filing Date
2022-05-24
Accepted
2022-05-23 21:38:33
Documents
13
Period of Report
2022-05-19
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A d354796d8ka.htm   iXBRL 8-K/A 26634
2 EX-99.2 d354796dex992.htm EX-99.2 78745
  Complete submission text file 0001193125-22-157739.txt   238039

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA cbio-20220519.xsd EX-101.SCH 2893
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20220519_lab.xml EX-101.LAB 18702
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20220519_pre.xml EX-101.PRE 11720
7 EXTRACTED XBRL INSTANCE DOCUMENT d354796d8ka_htm.xml XML 3886
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-51173 | Film No.: 22953687
SIC: 2834 Pharmaceutical Preparations